State Street Corp Cassava Sciences Inc Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Cassava Sciences Inc stock. As of the latest transaction made, State Street Corp holds 1,162,749 shares of SAVA stock, worth $30.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,162,749
Previous 1,176,977 1.21%
Holding current value
$30.3 Million
Previous $14.5 Million 135.42%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$9.57 - $35.08 $136,161 - $499,118
-14,228 Reduced 1.21%
1,162,749 $34.2 Million
Q2 2024

Aug 14, 2024
BUY
$12.35 - $26.11 $1.03 Million - $2.18 Million
83,499 Added 7.64%
1,176,977 $14.5 Million
Q1 2024

May 15, 2024
BUY
$18.44 - $26.41 $439,406 - $629,323
23,829 Added 2.23%
1,093,478 $22.2 Million
Q4 2023

Feb 14, 2024
BUY
$12.64 - $30.11 $556,905 - $1.33 Million
44,059 Added 4.3%
1,069,649 $24.1 Million
Q3 2023

Nov 14, 2023
BUY
$16.64 - $25.32 $1.22 Million - $1.86 Million
73,505 Added 7.72%
1,025,590 $17.1 Million
Q2 2023

Aug 14, 2023
SELL
$21.59 - $27.88 $2.31 Million - $2.98 Million
-106,864 Reduced 10.09%
952,085 $23.3 Million
Q1 2023

May 15, 2023
BUY
$23.46 - $36.44 $1.52 Million - $2.37 Million
64,903 Added 6.53%
1,058,949 $25.5 Million
Q4 2022

Feb 14, 2023
SELL
$27.82 - $44.16 $89,107 - $141,444
-3,203 Reduced 0.32%
994,046 $29.4 Million
Q3 2022

Nov 15, 2022
SELL
$16.33 - $51.06 $46,034 - $143,938
-2,819 Reduced 0.28%
997,249 $41.7 Million
Q2 2022

Aug 15, 2022
SELL
$17.22 - $38.47 $927,951 - $2.07 Million
-53,888 Reduced 5.11%
1,000,068 $28.1 Million
Q1 2022

May 16, 2022
BUY
$32.6 - $53.05 $2.54 Million - $4.13 Million
77,830 Added 7.97%
1,053,956 $39.1 Million
Q4 2021

Feb 14, 2022
BUY
$36.77 - $90.91 $1.36 Million - $3.37 Million
37,040 Added 3.94%
976,126 $42.7 Million
Q3 2021

Nov 15, 2021
BUY
$41.79 - $135.3 $2.89 Million - $9.36 Million
69,208 Added 7.96%
939,086 $58.3 Million
Q2 2021

Aug 16, 2021
BUY
$32.15 - $89.72 $5.9 Million - $16.5 Million
183,568 Added 26.75%
869,878 $74.3 Million
Q1 2021

May 17, 2021
BUY
$7.09 - $87.95 $1.69 Million - $20.9 Million
237,758 Added 53.01%
686,310 $30.9 Million
Q4 2020

Feb 16, 2021
BUY
$6.79 - $12.25 $652,179 - $1.18 Million
96,050 Added 27.25%
448,552 $3.06 Million
Q3 2020

Nov 10, 2020
BUY
$2.86 - $11.51 $336,896 - $1.36 Million
117,796 Added 50.19%
352,502 $4.06 Million
Q2 2020

Aug 14, 2020
BUY
$2.04 - $9.64 $478,800 - $2.26 Million
234,706 New
234,706 $723,000

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.04B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email